Lazard Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,168
Closed -$547K 1972
2026
Q1
$547K Buy
58,168
+23,374
+67% +$209K ﹤0.01% 1352
2025
Q4
$282K Buy
+34,794
New +$380K ﹤0.01% 1550
2024
Q1
Sell
-1,049
Closed -$23K 2085
2023
Q4
$23K Buy
1,049
+26
+3% +$564 ﹤0.01% 2041
2023
Q3
$25K Sell
1,023
-2,742
-73% -$69K ﹤0.01% 2064
2023
Q2
$105K Sell
3,765
-7,182
-66% -$178K ﹤0.01% 1559
2023
Q1
$244K Buy
10,947
+2,896
+36% +$75.9K ﹤0.01% 1265
2022
Q4
$213K Buy
8,051
+433
+6% +$14.1K ﹤0.01% 1287
2022
Q3
$216K Sell
7,618
-3,464
-31% -$89.1K ﹤0.01% 1257
2022
Q2
$230K Buy
11,082
+4,574
+70% +$85.7K ﹤0.01% 1242
2022
Q1
$141K Sell
6,508
-868
-12% -$18.8K ﹤0.01% 1315
2021
Q4
$204K Buy
7,376
+1,154
+19% +$28K ﹤0.01% 1273
2021
Q3
$132K Sell
6,222
-419
-6% -$7.86K ﹤0.01% 1356
2021
Q2
$109K Buy
6,641
+2,135
+47% +$32.6K ﹤0.01% 1320
2021
Q1
$56K Buy
+4,506
New +$47.8K ﹤0.01% 1386

Other funds holding CCRN

Lazard Asset Management's CCRN Position: Q2 2026 in Review

Lazard Asset Management sold out of Cross Country Healthcare (CCRN) in Q2 2026, closing a stake of 58,168 shares — an estimated $547K sold.

Lazard Asset Management first reported a position in CCRN in Q1 2021 and held it in 14 quarters. The position peaked at $547K in Q1 2026. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Lazard Asset Management reported no remaining Cross Country Healthcare position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 58,168 Cross Country Healthcare shares in Q2 2026, an estimated $547K.
  • Lazard Asset Management first reported a position in Cross Country Healthcare in Q1 2021 and held it in 14 quarters.
  • Lazard Asset Management's Cross Country Healthcare position peaked at $547K in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.